CMS’ innovation center should integrate pharmacists into Medicare alternative payment models to help control drug costs, according to the National Association of Chain Drug Stores, and the lobby recommends policies for doing so, including classifying pharmacists as providers. Center for Medicare and Medicaid Innovation Director Liz Fowler recently said the center would wait until Congress passes drug pricing legislation before determining the kinds of demonstrations it will run to control drug costs. Before Thanksgiving recess, House Democrats passed a $1.75...